Murine interleukin 4 transgenic heart allograft survival, prolonged with down-regulation of the Th1 cytokine mRNA in grafts

Transplantation

Volumn 64, Issue 1, 1997, Pages 152-157

  Takeuchi, Takumi ^a   Ueki, Tetsuo ^a   Sunaga, Shinji ^a   Ikuta, Koichi ^a   Sasaki, Yukihiro ^a   Li, Baoxing ^a   Moriyama, Nobuo ^a   Miyazaki, Jun Ichi ^a   Kawabe, Kazuki ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; INTERLEUKIN 10; INTERLEUKIN 4; MESSENGER RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GRAFT FAILURE; GRAFT SURVIVAL; HEART TRANSPLANTATION; HELPER CELL; IMMUNOLOGICAL TOLERANCE; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; TRANSGENE;

ANIMALS; CYTOKINES; DOWN-REGULATION; FEMALE; GRAFT SURVIVAL; HEART; HEART TRANSPLANTATION; INTERLEUKIN-4; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MYOCARDIUM; MYOSINS; PARAFFIN EMBEDDING; PROMOTER REGIONS (GENETICS); RNA, MESSENGER; SPLEEN; T-LYMPHOCYTES, HELPER-INDUCER; TRANSPLANTATION, HOMOLOGOUS;

EID: 0030851326     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199707150-00026     Document Type: Article

References (30)

1. Mosmann TR, Coffman RL. Th1 and Th2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 1989; 7: 143.
2. Pirmez C, Yamamura M, Uyemura K, Paes-Oilveira M, Conceicao-Silva F, Modlin RL. Cytokine patterns the pathogenesis of human leishmaniasis. J Clin Invest 1993; 91: 1390.
3. Yamamura M, Uyemura K, Deans RJ, et al. Defining protective responses to pathogens: cytokine profiles in leprosy lesions. Science 1991; 254: 277.
4. Dallman MJ, Wood KJ, Hamano K, et al. Cytokines and peripheral tolerance to alloantigen. Immunol Rev 1993; 133: 5.
5. Takeuchi T, Lowry RP, Konieczny B. Heart grafts in murine systems: the differential activation of Th2-like effectors in peripheral tolerance. Transplantation 1992; 53: 1281.
6. Ferraresso M, Tian L, Ghobrial R, Stepkowski SM, Kahan BD. Rapamycin inhibits production of cytotoxic but not monocytotoxic antibodies and preferentially activates T-helper 2 cells that mediate long-term survival of heart allografts in rats. J Immunol 1994; 153: 3307.
7. Akalin E, Hancock WW, Perico N, et al. Blocking cell microtubule assembly inhibits the alloimmune response in-vitro and prolongs renal-allograft survival by inhibition of Th1 and sparing of Th2 cell-function in-vivo. J Am Soc Nephrol 1995; 5: 1418.
8. Shirwan H, Cosenza CA, Wang HK, Wu GD, Makowka L, Cramer DW. Prevention of orthotopic liver allograft-rejection in rats with a short-term brequinar sodium therapy: analysis of intragraft cytokine gene expression. Transplantation 1994; 57: 1072.
9. Sayegh MH, Akalin E, Hancock WW, et al. CD28-B7 blockade after alloantigenic challenge in-vivo inhibits Th1 cytokines but spares Th2. J Exp Med 1995; 181: 1869.
10. + T cells in vivo: differential expression of IL-2 and IL-4 mRNA in recipients of cardiac allografts. J Immunol 1992; 148: 1308.
11. Mottram PL, Han WR, Purcell LJ, Mckenzi IFC, Hancock WW. Increased expression of IL-4 and IL-10 and decreased expression of IL-2 and interferon-gamma in long-surviving mouse heart allografts after brief CD4-monoclonal antibody therapy. Transplantation 1995; 59: 559.
12. Field EH, Rouse TM. Alloantigen priming after total lymphoid irradiation alters alloimmune cytokine responses. Transplantation 1995; 60: 695.
13. Orloff MS, Demara EM, Coppage ML, et al. Alterations of the interleukin-4 pathway in production of tolerance by mixed hematopoietic chimerism. Surgery 1995; 118: 212.
14. Chen NX, Field EH. Enhanced type-2 and diminished type-1 cytokines in neonatal tolerance. Transplantation 1995; 59: 933.
15. Farges O, Morris PJ, Dallman MJ. Spontaneous acceptance of rat-liver allografts is associated with an early down-regulation of intragraft interleukin-4 messenger-RNA expression. Hepatology 1995; 21: 767.
16. Steiger J, Nickerson PW, Steurer W, Moscovitchlopatin M, Strom TB. IL-2 knockout recipient mice reject islet-cell allografts. J Immunol 1995; 155: 489.
17. Levy AE, Alexander JW. Administration of intragraft interleukin-4 prolongs cardiac allograft survival in rats treated with donor-specific transfusion/cyclosporine. Transplantation 1995; 60: 405.
18. Rabinovitch A, Suarezpinzon WL, Sorensen O, Bleackley RC, Power RF, Rajotte RV. Combined therapy with interleukin-4 and interleukin-10 inhibits autoimmune diabetes recurrence in syngeneic islet-transplanted nonobese diabetic mice: analysis of cytokine messenger-RNA expression in the graft. Transplantation 1995; 60: 368.
19. + lymphoid engraftment. J Immunol 1994; 152: 1004.
20. Maeda H, Takata M, Takahashi S, Ogoshi S, Fujimoto S. Adoptive transfer of a T(H)2-like cell-line prolongs MHC class-II antigen disparate skin allograft survival in the mouse. Int Immunol 1994; 6: 855.
21. Niwa H, Yamamura K, Miyazaki J. Efficient selection for high-expression transfectant with a novel eukaryotic vector. Gene 1991; 108: 193.
22. Gulick J, Subramaniam A, Neumann J, Robbins J. Isolation and characterization of the mouse cardiac myosin heavy chain genes. J Biol Chem 1991; 266: 9180.
23. Subramaniam A, Jones WK, Gulick J, Wert S, Neumann J, Robbins J. Tissue-specific regulation of the α-myosin heavy chain gene promotor in transgenic mice. J Biol Chem 1991; 266: 24613.
24. Lowry RP, Wang K, Vernooij B, Harcus D. Lymphokine transcription in vascularized mouse heart grafts: effects of "tolerance" induction. Transplant Proc 1989; 21: 72.
25. Morgan CJ, Hernandez CJ, Ward JS, Orosz CG. Detection of cytokine mRNA in vivo by polymerase chain reaction, problems and solutions. Transplantation 1993; 56: 437.
26. Corry RJ, Winn HJ, Russell PS. Primarily vascularized allografts of hearts in mice. Transplantation 1973; 16: 343.
27. Moriyama N, Kurimoto S, Horie S, et al. Detection of α1-adrenoceptor subtypes in human hypertrophied prostate by in situ hybridization. Histochem J 1996; 28: 283.
28. Muller W, Kuhn R, Rajewsky K. Major histocompatibility complex class II hyperexpression on B cells in interleukin 4-transgenic mice does not lead to B cell proliferation and hypergammaglobulinemia. Eur J Immunol 1991; 21: 921.
29. Tepper RI, Levinson DA, Stanger BZ, Campos-Torres J, Abbas AK, Leder P. IL-4 induces allergic-like inflammatory disease and alters T cell development in transgenic mice. Cell 1990; 62: 457.
30. Lewis DB, Liggitt HD, Effmann EL, et al. Osteoporosis induced in mice by overproduction of interleukin 4. Proc Natl Acad Sci USA 1993; 90: 11618.